MarketPulse

ralinepag

2 articles
BenzingaBenzinga··Vandana Singh

United Therapeutics Surges 16.5% on Positive Lung Disease Trial Results

United Therapeutics stock surges 16.5% after TETON-1 Phase 3 study shows Tyvaso meets primary endpoint in lung fibrosis treatment, with priority FDA review expected by summer 2026.
UTHRFDA approvalclinical trial
BenzingaBenzinga··Vandana Singh

United Therapeutics' Ralinepag Shows 55% Drop in PAH Worsening, Stock Soars

United Therapeutics ($UTHR) stock rallies 3.98% after Phase 3 trial shows ralinepag reduces PAH worsening 55%, with FDA filing targeted for mid-2026.
UTHRFDA approvalPhase 3 trial